NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
NeoImmuneTech
NeoImmuneTech
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
AstraZeneca
University of California, San Diego
Inhibrx Biosciences, Inc
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Seattle Children's Hospital
Intensity Therapeutics, Inc.
Kineta Inc.
MultiVir, Inc.